Verve Therapeutics Inc
VERV
Market Cap$635.51M
Close$
$1.29
80.9% downside
Current Fair Value
80.9% downsideOvervalued by 80.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $635.51 Million |
|---|---|
| Enterprise Value | $86.46 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.12 |
| Beta | 0.0 |
| Outstanding Shares | 83,619,279 |
| Avg 30 Day Volume | 1,748,441 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.18 |
|---|---|
| PEG | -17.96 |
| Price to Sales | - |
| Price to Book Ratio | 0.96 |
| Enterprise Value to Revenue | 7.35 |
| Enterprise Value to EBIT | -0.39 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.87 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
ESG Score
No data
About Verve Therapeutics Inc
63 employees